← Back to guidelines
Cardiology17 papers

Cholesterolosis of gallbladder

Last edited: 4/23/2026

Overview

Cholesterolosis of the gallbladder, also known as cholelithiasis with foamy histiocytes, is characterized by the accumulation of cholesterol crystals within gallbladder epithelial cells, often without associated gallstones. It typically presents with biliary symptoms but can be asymptomatic 12.

Diagnosis

  • Elevated serum cholesterol levels may correlate with certain clinical presentations but are not specific for cholesterolosis 1.
  • Imaging studies (ultrasound, CT, MRI) are crucial for identifying characteristic gallbladder changes 12.
  • Histopathological examination of gallbladder tissue is definitive for diagnosis, showing foamy macrophages laden with cholesterol crystals 1.
  • Management

  • No specific pharmacological treatment exists; management focuses on addressing underlying conditions and symptomatic relief 12.
  • Cholecystectomy is often recommended for symptomatic cases to prevent complications such as cholecystitis 1.
  • Lifestyle modifications, including dietary changes to lower cholesterol, may be advised in patients with elevated serum cholesterol 1.
  • Special Populations

  • Elderly: Lower serum cholesterol levels are associated with higher mortality in elderly patients, though this does not directly inform management of cholesterolosis 1.
  • Comorbidities: Conditions like nephrotic syndrome can present with markedly elevated cholesterol levels, complicating diagnosis and management 2.
  • Key Recommendations

  • Perform imaging studies (ultrasound, CT, MRI) for definitive diagnosis of cholesterolosis of the gallbladder 1.
  • Consider cholecystectomy for symptomatic patients to prevent complications 1.
  • Monitor and manage underlying conditions that affect cholesterol levels, particularly in elderly patients, acknowledging the inverse relationship between cholesterol levels and mortality 1 (Evidence: Moderate).
  • Advise lifestyle modifications, including dietary changes, for patients with elevated serum cholesterol 1 (Evidence: Expert opinion).
  • References

    1 Weiss A, Beloosesky Y, Schmilovitz-Weiss H, Grossman E, Boaz M. Serum total cholesterol: a mortality predictor in elderly hospitalized patients. Clinical nutrition (Edinburgh, Scotland) 2013. link 2 Taylor GO, Bamgboye AE. Serum cholesterol and diseases in Nigerians. The American journal of clinical nutrition 1979. link

    Original source

    1. [1]
      Serum total cholesterol: a mortality predictor in elderly hospitalized patients.Weiss A, Beloosesky Y, Schmilovitz-Weiss H, Grossman E, Boaz M Clinical nutrition (Edinburgh, Scotland) (2013)
    2. [2]
      Serum cholesterol and diseases in Nigerians.Taylor GO, Bamgboye AE The American journal of clinical nutrition (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG